Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Peters, Lars ^a,b   Mocroft, Amanda ^c   Soriano, Vincent ^d   Rockstroh, Jürgen ^e,ak   Rauch, Andri ^f   Karlsson, Anders ^g   Knysz, Brygida ^h   Pradier, Christian ⁱ   Zilmer, Kai ^j,ab   Lundgren, Jens D ^a,b   Losso, M ^k   Kundro, M ^k   Vetter, N ^l   Zangerle, R ^m   Karpov, I ⁿ   Vassilenko, A ⁿ   Mitsura, V M ^o   Suetnov, O ^p   Clumeck, N ^q   De Wit, S ^q   Delforge, M ^q   Colebunders, R ^r   Vandekerckhove, L ^s   Hadziosmanovic, V ^t   Kostov, K ^u   Begovac, J ^v   Machala, L ^w   Jilich, D ^w   Sedlacek, D ^x   Nielsen, J ^y   Kronborg, G ^y   Benfield, T ^y   Larsen, M ^y   Gerstoft, J ^b   Katzenstein, T ^b   Hansen, A B E ^b   Skinhoj P ^b   Pedersen, C ^z   Ostergaard, L ^aa   Smidt, Jelena ^ac   Ristola, M ^ad   Katlama, C ^ae   Viard, J P ^af   Girard, P M ^ag   Livrozet, J M ^ah   Vanhems, P ^ai   Dabis, F ^aj   Neau, D ^aj   Schmidt, R ^al   van Lunzen, J ^am   Degen, O ^am   Stellbrink, H J ^an   Staszewski, S ^ao   Bogner, J ^ap   Fatkenheuer G ^aq   Kosmidis, J ^ar   Gargalianos, P ^ar   Xylomenos, G ^ar   Perdios, J ^ar   Panos, G ^as   Filandras, A ^as   Karabatsaki, E ^as   Sambatakou, H ^at   Banhegyi, D ^au   Mulcahy, F ^av   Yust, I ^aw   Turner, D ^aw   Burke, M ^aw   Pollack, S ^ax   Hassoun, G ^ax   Maayan, S ^ay   Vella, S ^az   Esposito, R ^ba   Mazeu, I ^ba   Mussini, C ^ba   Arici, C ^bb   Pristera, R ^bc   Mazzotta, F ^bd   Gabbuti, A ^bd   Vullo, V ^be   Lichtner, M ^be   Chirianni, A ^bf   Montesarchio, E ^bf   Gargiulo, M ^bf   Antonucci, G ^bg   Testa, A ^bg   Doffizi G ^bg   Vlassi, C ^bg   Zaccarelli, M ^bg   Antorini, A ^bg   Lazzarin, A ^bh   Castagna, A ^bh   Gianotti, N ^bh   Galli, M ^bi   Ridolfo, A ^bi   d'Arminio Monforte, A ^bj   Rozentale, B ^bk   Zeltina, I ^bk   Chaplinskas, S ^bl   Staub, T ^bm   Hemmer, R ^bm   Reiss, P ^bn   Ormaasen, V ^bo   Maeland, A ^bo   Bruun, J ^bo   Gasiorowski, J ^h   Horban, A ^bp   Bakowska, E ^bp   Grzeszczuk, A ^bq   Flisiak, R ^bq   Boron Kaczmarska, A ^br   Pynka, M ^br   Parczewski, M ^br   Beniowski, M ^bs   Mularska, E ^bs   Trocha, H ^bt   Jablonowska, E ^bu   Malolepsza, E ^bu   Wojcik, K ^bu   Antunes, F ^bv   Doroana, M ^bv   Caldeira, L ^bv   Mansinho, K ^bw   Maltez, F ^bx   Duiculescu, D ^by   Rakhmanova, A ^bz   Zakharova, N ^ca   Buzunova, S ^cb   Jevtovic, D ^cc   Mokras M ^cd   Stanekova D ^cd   Tomazic, J ^ce   Gonzalez Lahoz J ^d   Labarga, P ^d   Medrano, J ^d   Moreno, S ^cf   Rodriguez, J M ^cf   Clotet, B ^cg   Jou, A ^cg   Paredes, R ^cg   Tural, C ^cg   Puig, J ^cg   Bravo, I ^cg   Gatell, J M ^ch   Miro J M ^ch   Domingo, P ^ci   Gutierrez, M ^ci   Mateo, G ^ci   Sambeat, M A ^ci   Blaxhult, A ^g   Flamholc, L ^cj   Ledergerber, B ^ck   Weber, R ^ck   Francioli, P ^cl   Cavassini, M ^cl   Hirschel, B ^cm   Boffi, E ^cm   Furrer, H ^cn   Battegay, M ^co   Elzi, L ^co   Kravchenko, E ^cp   Chentsova, N ^cp   Frolov, V ^cq   Kutsyna, G ^cq   Servitskiy, S ^cr   Krasnov, M ^cs   Barton, S ^ct   Johnson, A M ^c   Mercey, D ^c   Phillips, A ^c   Johnson, M A ^c   Murphy, M ^cu   Weber, J ^cv   Scullard, G ^cv   Fisher, M ^cw   Leen, C ^cx   more..

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e UNIVERSITY OF BONN   (Germany)

^f UNIVERSITY OF BERN   (Switzerland)

^g STOCKHOLM SÖDER HOSPITAL   (Sweden)

^h WROCLAW MEDICAL UNIVERSITY   (Poland)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^j Tallin Children's Hospital   (Estonia)

^k HOSPITAL RAMOS MEJÍA   (Argentina)

^l Pulmologisches Zentrum   (Austria)

^m INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁿ BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^o GOMEL STATE MEDICAL UNIVERSITY   (Belarus)

^p Regional AIDS Centre   (Belarus)

^q SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^r INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^s GHENT UNIVERSITY HOSPITAL   (Belgium)

^t Klinicki Centar Univerziteta Sarajevo   (Bosnia and Herzegovina)

^u Infectious Diseases Hospital   (Bulgaria)

^v Ministarstva Zdravstva i Socijalne Skrbi RH   (Croatia)

^w UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^x CHARLES UNIVERSITY   (Czech Republic)

^y HVIDOVRE HOSPITAL   (Denmark)

^z ODENSE UNIVERSITY HOSPITAL   (Denmark)

^aa AARHUS UNIVERSITY HOSPITAL   (Denmark)

^ab WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^ac Nakkusosakond Siseklinik   (Estonia)

^ad HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ae PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^af HÔPITAL NECKER ENFANTS MALADES   (France)

^ag HÔPITAL SAINT ANTOINE   (France)

^ah EDOUARD HERRIOT HOSPITAL   (France)

^ai UNIVERSITÉ LYON 1   (France)

^aj INSERM   (France)

^ak UNIVERSITY HOSPITAL BONN   (Germany)

^al HANNOVER MEDICAL SCHOOL   (Germany)

^am UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^an IPM Study Center   (Germany)

^ao UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^ap LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^aq UNIVERSITY OF COLOGNE   (Germany)

^ar IASO GENERAL HOSPITAL   (Greece)

^as 1st IKA Hospital   (Greece)

^at Ippokration Genereal Hospital   (Greece)

^au Szent Laszlo Hospital   (Hungary)

^av ST JAMES S HOSPITAL   (Ireland)

^aw TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^ax RAMBAM MEDICAL CENTER   (Israel)

^ay HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^az ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^ba UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^bb OSPEDALI RIUNITI   (Italy)

^bc OSPEDALE CA FONCELLO   (Italy)

^bd SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^be SAPIENZA UNIVERSITY OF ROME   (Italy)

^bf MONALDI HOSPITAL   (Italy)

^bg NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^bh SAN RAFFAELE HOSPITAL   (Italy)

^bi UNIVERSITY OF MILAN   (Italy)

^bj Istituto di Clinica Malattie Infettive e Tropicale   (Italy)

^bk Infectology Centre of Latvia   (Latvia)

^bl Lithuanian AIDS Centre   (Lithuania)

^bm Centre Hospitalier   (Luxembourg)

^bn ACADEMIC MEDICAL CENTER   (Netherlands)

^bo ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^bp SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

^bq MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^br POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bs Osrodek Diagnostyki i Terapii AIDS   (Poland)

^bt MEDICAL UNIVERSITY OF GDANSK   (Poland)

^bu M Madurowicza I Oddzia Chorob   (Poland)

^bv HOSPITAL DE SANTA MARIA   (Portugal)

^bw HOSPITAL EGAS MONIZ   (Portugal)

^bx HOSPITAL CURRY CABRAL   (Portugal)

^by VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^bz Medical Academy Botkin Hospital   (Russian Federation)

^ca St Petersburg AIDS Centre   (Russian Federation)

^cb Nizhny Novgorod Center for AIDS and Infectious Diseases Prevention and Control   (Russian Federation)

^cc Institute for Infectious and Tropical Diseases   (Serbia)

^cd Derer 's University Hospital Slovakia   (Slovakia)

^ce UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^cf HOSPITAL RAMÓN Y CAJAL   (Spain)

^cg HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^ch HOSPITAL CLÍNIC   (Spain)

^ci Hospital Sant Pau   (Sweden)

^cj LUND UNIVERSITY HOSPITAL   (Sweden)

^ck UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^cl LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^cm GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^cn UNIVERSITY OF BERN   (Switzerland)

^co UNIVERSITY HOSPITAL BASEL   (Switzerland)

^cp Kiev Centre for AIDS   (Ukraine)

^cq Lugansk State Medical University   (Ukraine)

^cr Odessa Region AIDS Centre   (Ukraine)

^cs KHARKIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^ct CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^cu QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^cv IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^cw ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^cx WESTERN GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HYALURONIC ACID; VIRUS RNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREDICTION; RISK ASSESSMENT; VIRUS HEPATITIS; BLOOD; COMPLICATION; DISEASE COURSE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; BIOLOGICAL MARKERS; COINFECTION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; HYALURONIC ACID; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; YOUNG ADULT;

EID: 84878329914     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064283     Document Type: Article

References (41)

1. Missiha SB, Ostrowski M, Heathcote EJ, (2008) Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 134(6): 1699-1714.
2. Benhamou Y, Bochet M, Di MV, Charlotte F, Azria F, et al. (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30(4): 1054-1058.
3. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, et al. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360(9349): 1921-1926.
4. Myers RP, Fong A, Shaheen AA, (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 28(5): 705-712.
5. Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, et al. (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41(2): 257-264.
6. Butt AA, Khan UA, Shaikh OS, McMahon D, Dorey-Stein Z, et al. (2009) Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers. HIV Clin Trials 10(1): 25-32.
7. Cacoub P, Rosenthal E, Halfon P, Sene D, Perronne C, et al. (2006) Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life. J Viral Hepat 13(10): 678-682.
8. Guha IN, Rosenberg WM, (2008) Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clin Liver Dis 12(4): 883-900.
9. Mehta SH, Lau B, Afdhal NH, Thomas DL, (2009) Exceeding the limits of liver histology markers. J Hepatol 50(1): 36-41.
10. Eriksson S, Fraser JR, Laurent TC, Pertoft H, Smedsrod B, (1983) Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 144(1): 223-228.
11. Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, et al. (2005) Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol 4: 6.
12. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, et al. (1998) Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 5(3): 187-192.
13. Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, et al. (2008) Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 47(3): 789-798.
14. Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, et al. (2005) HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 40(5): 538-544.
15. Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, et al. (2010) Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 59(10): 1401-1409.
16. Guechot J, Serfaty L, Bonnand AM, Chazouilleres O, Poupon RE, et al. (2000) Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 32(3): 447-452.
17. Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, et al. (2009) Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. J Viral Hepat 16(7): 513-518.
18. Resino S, Bellon JM, Asensio C, Micheloud D, Miralles P, et al. (2010) Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis 10: 244.
19. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, et al. (2003) Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362(9377): 22-29.
20. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, et al. (2005) Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19(6): 593-601.
21. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, et al. (2005) Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 192(6): 992-1002.
22. Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, et al. (2008) Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 198(9): 1337-1344.
23. Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, et al. (2011) A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study. HIV Clin Trials 12(2): 109-117.
24. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, et al. (2002) Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35(3): 716-721.
25. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8): 646-649.
26. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4): 864-871.
27. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, et al. (2006) A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem. 52(10): 1887-1896.
28. Parkes J, Roderick P, Harris S, Day C, Mutimer D, et al. (2010) Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 59(9): 1245-1251.
29. Nunes D, Fleming C, Offner G, Craven D, Fix O, et al. (2010) Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection. Am J Gastroenterol 105(6): 1346-53.
30. Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, et al. (2005) Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 43(1): 78-84.
31. Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, et al. (2011) Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir Ther 16(5): 667-675.
32. Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, et al. (2005) HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 40(5): 538-544.
33. Vogel M, Rockstroh JK, (2009) Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS 4(3): 171-175.
34. Engstrom-Laurent A, Hallgren R, (1987) Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum 30(12): 1333-1338.
35. Wong CS, Gibson PR, (1998) Effects of eating on plasma hyaluronan in patients with cirrhosis: its mechanism and influence on clinical interpretation. J Gastroenterol Hepatol 13(12): 1218-1224.
36. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H, (1998) Post-prandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med 37(7): 568-575.
37. Baker J, Tracy R, for the INSIGHT SMART Study Group (2011) Pro- and Anti-coagulant Activity Among HIV-infected Patients in the Strategies for Management of Anti-Retroviral Therapy (SMART) Trial: Randomized comparisons of stopping and starting antiretroviral therapy. Abstract 811 at the 18th Conference on Retroviruses and Opportunistic Infection.
38. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, et al. (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5(10): e203.
39. Nunez M, (2010) Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology 52(3): 1143-1155.
40. Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, et al. (2012) Platelet count kinetics following Interruption of antiretroviral treatment: Results from the SMART study. AIDS 27(1): 59-68.
41. Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, et al. (2011) Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 203(11): 1637-1646.